Skip to main content
TSHA logo

TSHA

Taysha Gene Therapies, Inc.
$5.97 -0.22 (-3.55%) At close · Jul 16
Market Cap
$1.72B
Shares
287,361,020

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 191
Total Value: $1,181,797,543
Total Shares: 264,088,774
Showing 1–100 of 196 holdings by value · page 1 of 2

Institutional Ownership Trend

24 quarters

Holder Concentration

Across 192 13F filers
Top Holder
8.9%
Jun 2023 → Mar 2026 · range 8.7% – 22.0%
of institutional value
Top 5
39.4%
Jun 2023 → Mar 2026 · range 36.4% – 64.7%
of institutional value
Top 10
64.9%
Jun 2023 → Mar 2026 · range 60.4% – 80.3%
of institutional value
HHI
499
Jun 2023 → Mar 2026 · range 446 – 1,072
Broadly held
Showing 100 of 196
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1806310 CUSIP 877619106 13F (30d) 5 filings 5 filers Visit website Investor relations